中医药挽救新型冠状病毒肺炎引发的急性呼吸窘迫综合征一例

Shi-xu LIU; Kun XIA; Yong-jun BIAN; Guang-xi LI

doi:10.1007/s11655-021-3333-6

Your Location：

Home >

Browse articles >

中医药挽救新型冠状病毒肺炎引发的急性呼吸窘迫综合征一例

Case Report | Updated：2022-03-18

- 中医药挽救新型冠状病毒肺炎引发的急性呼吸窘迫综合征一例
- Chinese Medicine Rescues Acute Respiratory Dyspnea Syndrome Caused by COVID-19: A Case Report
- Chinese Journal of Integrative Medicine 2022年28卷第1期页码：76-80
- Affiliations：
  
  1.Department of Respiratory, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing (100053), China
  2.Graduate School of Beijing University of Chinese Medicine,Beijing (100053), China
- Author bio：
  
  Prof. LI Guang-xi, E-mail: lgx0410@163.com
- Funds：
  
  the China Academy of Chinese Medical Sciences(ZZ14-FY-005)
- DOI：10.1007/s11655-021-3333-6
  中图分类号：
- 纸质出版日期：2022-01-01，
  
  网络出版日期：2021-05-25，
  
  录用日期：2020-12-25
Scan for full text
Shi-xu LIU, Kun XIA, Yong-jun BIAN, 等. 中医药挽救新型冠状病毒肺炎引发的急性呼吸窘迫综合征一例[J]. Chinese Journal of Integrative Medicine, 2022,28(1):76-80.

Shi-xu LIU, Kun XIA, Yong-jun BIAN, et al. Chinese Medicine Rescues Acute Respiratory Dyspnea Syndrome Caused by COVID-19: A Case Report[J]. Chinese Journal of Integrative Medicine, 2022,28(1):76-80.
Shi-xu LIU, Kun XIA, Yong-jun BIAN, 等. 中医药挽救新型冠状病毒肺炎引发的急性呼吸窘迫综合征一例[J]. Chinese Journal of Integrative Medicine, 2022,28(1):76-80. DOI： 10.1007/s11655-021-3333-6.

Shi-xu LIU, Kun XIA, Yong-jun BIAN, et al. Chinese Medicine Rescues Acute Respiratory Dyspnea Syndrome Caused by COVID-19: A Case Report[J]. Chinese Journal of Integrative Medicine, 2022,28(1):76-80. DOI： 10.1007/s11655-021-3333-6.

摘要

新型冠状病毒肺炎疫情肆虐

对全球健康造成了毁灭性的打击. 截止目前

世界范围内200多个国家已有确诊病例2千多万

死亡病例达530多万. 当前仍缺乏对新型冠状病毒的有效抗病毒药物

以隔离治疗、对症支持治疗为主

亟待探索缓解或治愈本病的有效手段. 中国中医科学院广安门医院的李光熙教授拥有20余年的临床经验

他在武汉疫情最严重

医疗资源最紧张时

创新采用人参败毒散配合中药透皮治疗

挽救了一例并发急性呼吸窘迫综合征的新冠肺炎患者. 本病例证实中医药能极好地缓解新冠肺炎患者的高热、咳嗽和其他症状

对新冠肺炎的治疗提供了另一种思路.

Abstract

关键词

Keywords

references

Hani C, Trieu NH, Saab I, Dangeard S, Bennani S,Chassagnon G, et al. COVID-19 pneumonia: a review of typical CT findings and differential diagnosis. Diagn Interv Imag 2020;101:263-268.

The National Health Commission of People's Republic of China. Interpretation of new coronavirus pneumonia diagnosis and treatment plan (trial version 8). Accessed August 19, 2020. Available at http://www.nhc.gov.cn/yzygj/s7653p/202008/0a7bdf12bd4b46e5bd28ca7f9a7f5e5a/files/a449a3e2e2c94d9a856d5faea2ff0f94.pdfhttp://www.nhc.gov.cn/yzygj/s7653p/202008/0a7bdf12bd4b46e5bd28ca7f9a7f5e5a/files/a449a3e2e2c94d9a856d5faea2ff0f94.pdf.

COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU).Accessed April 13, 2021. Available at https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/D.Ahttps://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/D.A.

Dunlop DD, Song J, Semanik PA, Sharma L, Bathon JM,Eaton CB, et al. Relation of physical activity time to incident disability in community dwelling adults with or at risk of knee arthritis: prospective cohort study. BMJ 2014;348:g2472.

Siemieniuk RA, Bartoszko JJ, Ge L, Zeraatkar D, Izcovich A, Kum E, et al. Drug treatments for COVID-19: living systematic review and network meta-analysis. BMJ 2020;370:m2980.

Kim PS, Read SW, Fauci AS. Therapy for early COVID-19:a critical need. JAMA 2020;324:2149-2150.

Tong XL, Li XY, Zhao LH, Li QW, Yang YY, Lin ZQ, et al.Discussing the prevention and treatment strategy of new coronavirus pneumonia with traditional Chinese medicine from the perspective of "cold and dampness". J Tradit Chin Med (Chin) 2020;66:465-470,553.

Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis 2020;20:911-919.

Kulkarni K, Karssiens T, Kumar V, Pandit H. Obesity and osteoarthritis. Maturitas 2016;89:22-28.

Ng M, Fleming T, Robinson M, Thomson B, Graetz N,Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-781.

NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 2016;387:1377-1396.

Kim H, Jang M, Kim Y, Choi J, Jeon J, Kim J, et al. Red ginseng and vitamin C increase immune cell activity and decrease lung inflammation induced by influenza A virus/H1N1 infection. J Pharm Pharmacol 2016;68:406-420.

Wang Y, Jung YJ, Kim KH, Kwon Y, Kim YJ, Zhang Z, et al.Antiviral activity of fermented ginseng extracts against a broad range of influenza viruses. Viruses 2018;10:471.

Huang H. Thinking of new coronavirus pneumonia based on classic Chinese medicine. J Nanjing Univ Tradit Chin Med (Chin) 2020;63:152-156.

Liu Y, Liu JB, Peng W. Discussion on network pharmacology of the mechanism of action of Renshen Baidu Powder in the treatment of novel coronavirus pneumonia. J Chin Med Mater (Chin) 2020;6:1536-1544.

Xu J, Pan LJ, Jia CS. Exploration on the feasibility of moxibustion in prevention and treatment of COVID-19 from the perspective of modern medical mechanism. World J Acupunct Moxibust (Chin) 2020;30:81-84.

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

暂无数据